Loading
IP
InnoCan Pharma Corporation Stock: price and insider trades · Canada
InnoCan Pharma Corporation: what insiders have been doing
InnoCan Pharma Corporation belongs to the Food & Beverage sector. Filings by its managers are published through SEDI. InnoCan Pharma Corporation has had no insider filing for more than a year; the last one goes back to 2 July 2025.
Over the whole record (from 2019), the tally stands at 1 purchase and 2 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€172
1 ops. · all time
Sell Volume
€3,118
2 ops. · all time
Who traded when
BuySalePeter David Bloch2 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,477 of 26,284 companies
37.9
score / 100
Value41
Quality35
FCF yld5.6%
Earn yld-13%
EV/EBITDA·
ROE-12%
Gross mgn90%
Net mgn-4.2%
Debt/EBITDA7.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$1.90
Analyst consensus
Income statement
RevenueCA$26.6M
Gross profitCA$23.9M90% margin
EBITDACA$130k0% margin
Net income-CA$1.1M-4.1% margin
Valuation
P/Book1.3x
Beta0.30
Balance sheet & cash
Market capCA$8.5M
Total debtCA$930k
Free Cash FlowCA$479k
Debt / Equity22%
Profitability & ownership
ROE-11.8%
ROA-20.1%
% insiders19.3%
% institutions0.0%
Last declaration on 2 July 2025
Declarations40 total
500 shares@ CA$0.161.6% of flowCommon SharesTSXSEDI:4538701
32,000 shares@ CA$0.1598.4% of flowCommon SharesTSXSEDI:4538698
100,000 shares@ CA$0.25Common SharesTSXSEDI:4351159
Common SharesTSXSEDI:4288411
117,000 sharesCommon SharesTSXSEDI:4288404
43,333 sharesCommon SharesTSXSEDI:4288405
180,000 sharesCommon SharesTSXSEDI:4288381
Common SharesTSXSEDI:4288379
Common SharesTSXSEDI:4288391
222,222 sharesCommon SharesTSXSEDI:4288345
117,000 sharesCommon SharesTSXSEDI:4288393
1,857,150 sharesCommon SharesTSXSEDI:4288347
Common SharesTSXSEDI:4288344
72,222 sharesCommon SharesTSXSEDI:4288412
Common SharesTSXSEDI:4288357
1,050,000 sharesCommon SharesTSXSEDI:4288362
177,777 sharesCommon SharesTSXSEDI:4288359
66,666 sharesCommon SharesTSXSEDI:4288380
43,333 sharesCommon SharesTSXSEDI:4288395
Common SharesTSXSEDI:4288328
177,777 sharesCommon SharesTSXSEDI:4288330
360,000 sharesCommon SharesTSXSEDI:4288332
100,000 sharesCommon SharesTSXSEDI:4182349
1,130,434 shares@ CA$0.2327.9% of flowCommon SharesTSXSEDI:4167982
100,000 sharesCommon SharesTSXSEDI:4116317
25 of 40 declarations
About InnoCan Pharma Corporation
InnoCan Pharma Corporation is a company focused on developing pharmaceutical products based on cannabis. It aims to provide innovative solutions for health and wellness.
